--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "ASE TTE" developer_entity: "Medmovie, Inc." bundle_id: "com.redpixelstudios.medmovie.ase.tte" app_store_id: "656925654" category: "Medical" primary_platform: "ios" primary_monetization: "Paid" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "N/A" report_date: "2026-04-03" report_version: "N/A" total_reviews: 0 confidence: "low" confidence_score: 0.05 data_age_days: 75 intelligence_version: 2 nemesis: "EchoSource" competitor_count: 11 tags: ["medical", "paid", "mobile app", "app review", "app analysis", "medical", "professionals", "students"] canonical_url: "https://marlvel.ai/apps/com-redpixelstudios-medmovie-ase-tte" license: "CC-BY-NC 4.0" last_verified: "2026-04-18T01:11:44.450Z" --- # ASE TTE App Audit > **TL;DR:** ASE TTE is a medical app by Medmovie, Inc., available on iOS. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** ASE TTE is a medical app by Medmovie, Inc.. ## Metadata & Market Performance - **Publisher:** Medmovie, Inc. - **Category:** Medical - **Target Audience:** Medical professionals or students requiring specialized clinical reference material, specifically related to Transthoracic Echocardiography (TTE). - **Platforms:** iOS - **Version Audited:** N/A - **Audit Date:** 2026-04-03 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.05/1.0) - **App Store ID (iOS):** 656925654 - **Bundle ID:** com.redpixelstudios.medmovie.ase.tte - **Data Window:** Analysis based on signals collected up to 2026-04-03 ## Executive Snapshot ASE TTE is a specialized medical reference tool for Transthoracic Echocardiography (TTE), targeting medical professionals and students. It provides authoritative clinical standards and diagnostic algorithms in a portable, paid format. The app recently entered the US App Store charts at #88 in the Paid Medical category, signaling a successful niche launch. ## App DNA (Features & Intent) - **[Differentiator] TTE Clinical Reference:** Comprehensive database of transthoracic echocardiography standards and measurements. - **[Standard] Diagnostic Criteria:** Specialized algorithms for cardiac imaging assessment. - **[Standard] Professional Utility:** Designed for high-stakes clinical environments and educational reference. * *User Intent:* Users seek enhanced value through premium features. ## Monetization Strategy - **Model:** Paid - **Tiers:** One-time purchase at $4.99 - **Price:** iOS: $4.99 - **Analysis:** The app utilizes a straightforward premium paid model, common for specialized medical reference or educational tools, avoiding recurring subscription costs. ## SWOT Analysis **Core Strengths:** - High authority and specialized focus on TTE standards - Simple, transparent one-time pricing model ($4.99) - Clear utility for a high-value professional demographic - Recent positive momentum in App Store rankings (#88 Paid Medical) **Critical Frictions:** - Lack of cross-platform availability (iOS only) - Minimal digital footprint (no website or social media presence) - Zero visible user reviews to build social proof - Limited feature set compared to broader cardiology hub apps **Growth Levers:** - Expansion to Android to capture the full medical professional market - Potential to partner with hardware manufacturers for integrated reference - Introduction of institutional licensing for hospital systems - Developing a content marketing strategy to build authority **Market Threats:** - Free guideline apps from major societies (ESC/ACC) - Disruptive AI-driven imaging software automating measurements - Competitors like EchoSource offering broader feature sets - Subscription-based competitors with higher R&D budgets ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### ASE TTE vs EchoSource — Head to Head - **EchoSource** by Mobile-Source, LLC: The most direct competitor providing a comprehensive mobile reference for echocardiography criteria, measurements, and diagnostic algorithms. ### Contenders (Strong Challengers) - **Pocket Echo** by Giovanni Di Salvo: Provides a portable clinical manual for echocardiography, focusing on the same professional user base and measurement standards. - **Valve in Valve** by UBQO Limited: While focused on valve procedures, it is a critical imaging reference tool used by the same echo-specialist audience for procedural planning. - **TEE Standard Views** by University Health Network: A specialized educational tool for cardiac imaging views, directly competing for the attention of medical students and cardiology fellows. - **Echocardiography Atlas** by Episodic Health: A visual reference library of echocardiographic findings that serves as a direct educational alternative to ASE's reference material. ### Peers (What They Do Better) - **ESC Pocket Guidelines** by European Society of Cardiology: The European equivalent to ASE guidelines, providing the primary alternative clinical standards for echocardiography in international markets. - **ACC Guideline Hub** by American College of Cardiology: The broader clinical ecosystem app that includes imaging guidelines and diagnostic criteria relevant to TTE users. - **MDCalc Medical Calculator** by MDCalc: Contains numerous cardiology and echo-specific calculators (like EROA and PISA) that users might use instead of a dedicated echo app. - **POCUS: Ultrasound** by POCUS Education: Focuses on point-of-care ultrasound which includes basic TTE views, targeting the growing market of non-cardiologist echo users. ### New Kids on the Block (What's Innovative) - **Butterfly iQ — Ultrasound** by Butterfly Network: A disruptive hardware-software combination that is redefining how TTE is performed and referenced at the bedside. - **Echo-Log** by Echo-Log: A rising utility for sonographers to track cases and measurements, capturing the workflow of the professional echo user. ## The "So What?" (Strategic Takeaway) {#so-what} ASE TTE is an established medical app that is a paid app. **Strategic Opportunity:** While ASE TTE benefits from high authority and specialized focus on tte standards, its vulnerability lies in lack of cross-platform availability (ios only). A challenger could exploit this by focusing on expansion to android to capture the full medical professional market. **Best for:** Medical professionals or students requiring specialized clinical reference material, specifically related to Transthoracic Echocardiography (TTE). ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Confidence | Low | | Pricing Model | Paid | | Platforms | iOS | | Key Features | 3 analyzed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **ASE TTE** (this app) | N/A/5 | N/A | Medmovie, Inc. | | [Vulvar Pain Algorithm](https://marlvel.ai/apps/com-washgyn-vestibulodynia) | N/A/5 | N/A | Jennifer Lanoff | | [Total Reflexology-3D](https://marlvel.ai/apps/com-acupuncturelearning-totalreflexology) | 4.0/5 | N/A | GraphicVizion | | [CardioGenetics](https://marlvel.ai/apps/com-scd-risk-calculator) | N/A/5 | N/A | MARK EMILE PEPIN | | [ECGsource](https://marlvel.ai/apps/com-ecgsource-applicationname) | 3.0/5 | N/A | ECGsource LLC | | [My F1rst Steps](https://marlvel.ai/apps/com-myfirststeps-www) | 5.0/5 | N/A | My First Steps LLC | ## Company Profile - **Developer:** Medmovie, Inc. ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/ase-tte/id656925654?uo=2) - **Sources:** App store metadata. ## Related Intel Reports - [*Vulvar Pain Algorithm*](https://marlvel.ai/apps/com-washgyn-vestibulodynia) (Jennifer Lanoff) — N/A Rating | N/A Sentiment - [*Total Reflexology-3D*](https://marlvel.ai/apps/com-acupuncturelearning-totalreflexology) (GraphicVizion) — 4.0/5 Rating | N/A Sentiment - [*CardioGenetics*](https://marlvel.ai/apps/com-scd-risk-calculator) (MARK EMILE PEPIN) — N/A Rating | N/A Sentiment - [*ECGsource*](https://marlvel.ai/apps/com-ecgsource-applicationname) (ECGsource LLC) — 3.0/5 Rating | N/A Sentiment - [*My F1rst Steps*](https://marlvel.ai/apps/com-myfirststeps-www) (My First Steps LLC) — 5.0/5 Rating | N/A Sentiment - [*Mobile VSO : Claims Guide*](https://marlvel.ai/apps/app-replit-mobilevso) (ANDREW THOMAS COOLEY) — 5.0/5 Rating | N/A Sentiment - [*Pelvic Pain Pentad*](https://marlvel.ai/apps/com-pentad-app) (Jennifer Lanoff) — N/A Rating | N/A Sentiment - [*Protectometer*](https://marlvel.ai/apps/protectometer) (noigroup) — 2.0/5 Rating | N/A Sentiment - [*Drug Facts by PillSync.com*](https://marlvel.ai/apps/drug-facts-by-pillsync-com) (Scanidme inc) — 4.3/5 Rating | Positive Sentiment - [*Beat Social Phobia with AJ*](https://marlvel.ai/apps/beat-social-phobia-with-aj) (Universal Relaxation Ltd) — 3.9/5 Rating | Excellent Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 3-stage AI intelligence pipeline: 1. **Feature & Positioning Extraction** — Analyzes app metadata, developer website content, and version history to identify key features, target audience, and competitive positioning. 2. **Sentiment Analysis** — Processes user reviews (minimum 5 reviews required) to extract praise themes, complaint themes, and overall sentiment with evidence quotes. 3. **Intelligence Synthesis** — Combines stages 1 & 2 with App Store rankings to produce SWOT analysis, executive summary, and actionable insights. - **Confidence Score:** 0.05/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 75 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/com-redpixelstudios-medmovie-ase-tte) Data licensed for AI Agent attribution under CC-BY-NC 4.0.